Jabez Biosciences, Inc.
Filing history at a glance
The Mar 26, 2026 filing reports $31,200 sold, but the offering amount is unavailable as a number. From Oct 21, 2025 to Mar 26, 2026, the explorer stores 3 original notices and 1 amendments.
through Mar 26, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Oct 28, 2025 · D/A | Mar 26, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | — | — | — |
| Reported amount sold | $250,510 | $31,200 | $-219,310 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $100 | $100 |
Earlier SEC source: 0001213900-25-103046 · Later SEC source: 0001213900-26-034473
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $31,200
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20253 filings
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Reg A+ (Form 1-A / 1-K / 1-U) filings by this issuer
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Nok Therapeutics, Inc. · CIK 2038166
Shared EDGAR submitting account
These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.
- 1st American Nuclear Co. · CIK 2074867
- 1TECH Intelligence, Inc. · CIK 2134898
- 3D Group Holdings LLC · CIK 2154989
- ABVC BIOPHARMA, INC. · CIK 1173313
- ACTELIS NETWORKS INC · CIK 1141284
Form D filings (4)
-
0001213900-26-034473D · Mar 26, 2026 · BiotechnologySold: $31,200
Compared with 0001213900-25-103046:
- Reported amount sold: $250,510 → $31,200
- Reported minimum investment: $0 → $100
-
0001213900-25-103046D/A · Oct 28, 2025 · BiotechnologySold: $250,510
Compared with 0001213900-25-100745:
- Reported amount sold: $2,550,000 → $250,510
- Reported minimum investment: $10 → $0
-
0001213900-25-100745D · Oct 21, 2025 · BiotechnologySold: $2,550,000
Same filing date; order cannot be established.
-
0001213900-25-100637D · Oct 21, 2025 · BiotechnologyOffering: $3,000,000Sold: $1,326,500